On Nov. 3, Waters reported third-quarter results that included 10% organic, constant-currency revenue growth and 21% adjusted EPS growth to $4.10, or above its $3.95 to $4.05 outlook. Management also increased its 2026 guidance and gave an initial view for 2027.
Waters' analytical instruments remain the gold standard in several applications, especially LC-MS for biopharmaceutical firms, where regulations preserve consistent recurring sales for many years.
With the recent BD merger, Waters could run into integration issues and other challenges while transitioning from a very focused firm to a more diverse one.
|
Metric
|
WAT
|
TMO
|
A
|
|---|---|---|---|
Price/Earnings (Normalized) | 34.18 | 28.57 | 29.24 |
Price/Book Value | 3.00 | 4.78 | 6.78 |
Price/Sales | 7.04 | 5.57 | 6.81 |
Price/Cash Flow | 28.78 | 25.32 | 26.48 |
|
Metric
|
WAT
|
TMO
|
A
|
|---|---|---|---|
Quick Ratio | 1.05 | 1.23 | 1.41 |
Current Ratio | 1.86 | 1.81 | 2.05 |
Interest Coverage | 2.23 | 5.52 | 16.08 |
|
Metric
|
WAT
|
TMO
|
A
|
|---|---|---|---|
Return on Assets (Normalized) | 7.79% | 8.32% | 13.27% |
Return on Equity (Normalized) | 13.28% | 17.48% | 24.92% |
Return on Invested Capital (Normalized) | 10.35% | 10.45% | 16.95% |
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|#yGjFV<# | LOCK|$?r | $262B | |||
| Danaher Corp
DHR
| LOCK|r#v&z$zq | LOCK|>k | $165B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|!%@?!lH | LOCK|m%f | $55B | |||
| Agilent Technologies Inc
A
| LOCK|HTzc&CQr | LOCK|dpm | $50B | |||
| IQVIA Holdings Inc
IQV
| LOCK|L&MNWJ | LOCK|?Fqrq | $43B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|$cwp^@s | LOCK|Dl>#$ | $35B | |||
| Illumina Inc
ILMN
| LOCK|lTG>?K | LOCK|$Z^Q | $34B | |||
| Labcorp Holdings Inc
LH
| LOCK|!s&yN@y | LOCK|%>rzK | $30B | |||
| Quest Diagnostics Inc
DGX
| LOCK|w$VBz@% | LOCK|R<H^ | $28B |
United States